Abstract
Objective: Systemic lupus erythematosus (SLE) is a chronic connective tissue disease caused by autoimmune,
immunological disorders which can effect many organs and systems. The aim of this study was to evaluate the
complaints, clinical and laboratory findings of patients with SLE.
Material and Methods: This study was performed between January 2001 and January 2014 by the Department of
Child Nephrology-Rheumatology with the diagnosis of SLE. In this study, clinical and laboratory findings, treatment,
organ involvement of the patients, who were followed up with the diagnosis of SLE, were recorded.
Results: Thirteen patients (10 girls, 3 boys) who received 4 or more of 11 SLE criteria renewed in 1997 by the American
College of Rheumatology (ACR) or who had consistent findings with lupus nephritis by kidney biopsy were included in
the study. There were 10 female (76.9%), 3 male (23.1%). Female / male ratio was 3.3 and mean age of 12.8 ± 2.79
(6-17 years). The mean follow-up period was 8.1 ± 2.34 years (4-13 years).
At the time of admission, 6 of the patients had rash (46.1%), 4 had edema in the legs (30.7%), 2 had swelling and pain in the joints (15.3%), 1 had chest and joint pain (7.6%) and 1 had pallor complaint (7.6%). In follow-up, 2 patients had skin, 3 had hematological, 5 had joint, 1 had serositis / pericardial and 1 patient had neurological disease
involvement. The rate of renal involvement was 84.6%. Three patients had high creatinine levels at admission and 5 patients had nephrotic
proteinuria. No correlation was found between proteinuria and creatinine at presentation and histopathological examination.
Conclusion: In this study, SLE, which started in childhood, had more than one system and organ kept at the time of diagnosis. It should
be kept in mind that SLE may present with different clinical and laboratory findings in childhood, as morbidity and mortality can be reduced
by appropriate diagnosis and treatment.
Keywords: Childhood, Nephritis
References
- 1. Ravelli A,Duarte-Salazar C, Buratti S, Reiff A, Bernstein B,
- Maldonado-Velazquez MR, et al. Arthritis Rheum 2003;15:501-7.
- 2. Lehman TJ. Systemic lupusery thematosus in children and
- adolescents. In: Dubois’ Systemic Lupus Erythematosus, 5th ed,
- Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.
- 3. Stichweh D, Arce E, Pascual V. Update on pediatric systemic lupus
- erythematosus. Curr Opin Rheumatol 2004;16:577.
- 4. Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome
- antibodies a better diagnostic marker than anti-dsDNA antibodies
- for systemic lupus erythematosus? A systematic review and a
- study of metanalysis. Autoimmun Rev 2012;12:97-106.
- 5. Vangelista A, Stipo L, Canova C, Frascà GM, Iannelli S, Nanni-
- Costa A, Bonomini V. 1996. Lupus nephritis: the value of
- biochemical and immunological monitoring of disease activity. Ren
- Fail 1996;18:755-63.
- 6. Textbook of Pediatric Rheumatology 7th edition, sectionthree,
- systemic connectivet issue diseases 2016;285-448.5
- 7. Garin EH, Donnelly WH, Shulman ST, Fernandez R, Finton C,
- Williams RL, et al. The significance of serial measurements of serum
- complement C3 and C4 componentsand DNA binding capacity in
- patients with lupus nephritis. Clin Nephrol 1979;12:148-55.
- 8. Schmugge M, Revel-Vilk S, Hiraki L, Rand ML,Blanchette VS,
- Silverman ED. Thrombocytopenia and thromboembolism in
- pediatric systemic lupus erythematosus.J Pediatr 2003;143:666-
- 9.
- 9. Lehman TJ. Systemic lupusery thematosus in children and
- adolescents. In: Dubois’ Systemic Lupus Erythematosus, 5th ed,
- Wallace DA, Hahn B (Eds), WB Saunders, Philadelphia 1996.